IL147902A0 - C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof - Google Patents

C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

Info

Publication number
IL147902A0
IL147902A0 IL14790200A IL14790200A IL147902A0 IL 147902 A0 IL147902 A0 IL 147902A0 IL 14790200 A IL14790200 A IL 14790200A IL 14790200 A IL14790200 A IL 14790200A IL 147902 A0 IL147902 A0 IL 147902A0
Authority
IL
Israel
Prior art keywords
prostate cancer
human prostate
antigen expressed
type lectin
transmembrane antigen
Prior art date
Application number
IL14790200A
Other languages
English (en)
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of IL147902A0 publication Critical patent/IL147902A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14790200A 1999-08-12 2000-08-11 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof IL147902A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14893599P 1999-08-12 1999-08-12
PCT/US2000/022065 WO2001012811A1 (fr) 1999-08-12 2000-08-11 Antigene transmembranaire lectine du type c exprime dans le cancer humain de la prostate et ses utilisations

Publications (1)

Publication Number Publication Date
IL147902A0 true IL147902A0 (en) 2002-08-14

Family

ID=22528098

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14790200A IL147902A0 (en) 1999-08-12 2000-08-11 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
IL147902A IL147902A (en) 1999-08-12 2002-01-30 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
IL197988A IL197988A (en) 1999-08-12 2009-04-05 Antibody or fragment thereof that specifically binds to a pc-lectin polypeptide

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL147902A IL147902A (en) 1999-08-12 2002-01-30 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
IL197988A IL197988A (en) 1999-08-12 2009-04-05 Antibody or fragment thereof that specifically binds to a pc-lectin polypeptide

Country Status (13)

Country Link
US (6) US6602501B1 (fr)
EP (2) EP1992695B1 (fr)
JP (3) JP4373637B2 (fr)
AT (2) ATE420175T1 (fr)
AU (5) AU774436B2 (fr)
CA (1) CA2380550C (fr)
CY (2) CY1110256T1 (fr)
DE (2) DE60041333D1 (fr)
DK (2) DK1992695T3 (fr)
ES (2) ES2355428T3 (fr)
IL (3) IL147902A0 (fr)
PT (2) PT1200590E (fr)
WO (1) WO2001012811A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2005205752B2 (en) * 1999-03-23 2007-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP4174183B2 (ja) * 1999-03-23 2008-10-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードする核酸
EP1046651A1 (fr) * 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition et méthode pour moduler l'interaction des cellules dendritiques et les cellules T
PT1200590E (pt) 1999-08-12 2009-03-24 Agensys Inc Antigénio transmembranar lectina tipo c expresso em cancro da próstata humano e utilizações do mesmo
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
US7449548B2 (en) * 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
ATE555124T1 (de) * 2004-08-16 2012-05-15 Agensys Inc Nukleinsäuren und entsprechende proteine 58p1d12 zum nachweis von krebs
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
GB0426823D0 (en) 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
GB0426822D0 (en) * 2004-12-07 2005-01-12 Precisense As Sensor for detection of glucose
US9267937B2 (en) * 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
EP2007435B1 (fr) 2006-03-31 2019-12-18 Massachusetts Institute Of Technology Système pour l'administration ciblée d'agents thérapeutiques
CA2652280C (fr) 2006-05-15 2014-01-28 Massachusetts Institute Of Technology Polymeres pour particules fonctionnelles
WO2007137117A2 (fr) * 2006-05-17 2007-11-29 Massachusetts Institute Of Technology Administration de médicaments dirigée par aptamères
WO2007150030A2 (fr) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Synthèse microfluidique de nanoparticules organiques
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
US9217129B2 (en) * 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
WO2008124634A1 (fr) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Micelles inverses encapsulées par un polymère
US20090074828A1 (en) 2007-04-04 2009-03-19 Massachusetts Institute Of Technology Poly(amino acid) targeting moieties
CN105770878A (zh) 2007-10-12 2016-07-20 麻省理工学院 疫苗纳米技术
WO2010022279A1 (fr) * 2008-08-20 2010-02-25 Agensys, Inc. Anticorps et molécules associées qui se lient à des protéines 58p1d12
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) * 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
CN105238781B (zh) * 2015-11-06 2018-02-16 福建省农业科学院果树研究所 基于转录组序列开发的李ssr标记引物对及其应用
US10543288B2 (en) 2017-04-28 2020-01-28 Medtronic Minimed, Inc. Modified-dextrans for use in optical glucose assays
US10792378B2 (en) 2017-04-28 2020-10-06 Medtronics Minimed, Inc. Using a blue-shifted reference dye in an optical glucose assay

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0206448B1 (fr) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hémoglobine liée à un poly(oxyde d'alkylène)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
CA2064555A1 (fr) 1990-06-27 1991-12-28 Arnold J. Levine Sondes pour detecter p53 mutant
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5879898A (en) * 1992-11-20 1999-03-09 Isis Innovation Limited Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
DK0773952T3 (da) 1994-07-20 2004-03-22 Inst Genetics Llc Interaktionsfældesystemer til påvisning af proteininteraktioner
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
ATE352638T1 (de) 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
US5681923A (en) * 1995-10-06 1997-10-28 Platt; David Tumor derived carbohydrate binding protein
US6476192B1 (en) * 1996-04-15 2002-11-05 Nicola C. Lally Recombinant antigens useful for the serodiagnosis of neosporosis
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ES2183166T3 (es) 1996-04-26 2003-03-16 Massachusetts Inst Technology Ensayo de cribado por triple hibrido.
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
WO1998016628A1 (fr) 1996-10-15 1998-04-23 The Regents Of The University Of California Modeles animaux de la progression du cancer de la prostate chez l'humain
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
EP2314625B1 (fr) 1996-12-03 2014-05-07 Amgen Fremont Inc. Mammifères transgèniques obtenus par génie génétique contenant des loci des immunoglobulines humaines qui comprennent plusieurs régions de VH et de Vkappa, et anticorps aussi obtenus
US7435793B2 (en) 1998-05-15 2008-10-14 Genentech, Inc. Peptides that induce chondrocyte redifferentiation
US20030004311A1 (en) 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7285625B2 (en) * 1997-06-18 2007-10-23 Genentech, Inc. PRO536 polypeptides
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030166104A1 (en) 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030027262A1 (en) 1997-09-18 2003-02-06 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7160985B2 (en) 1997-10-29 2007-01-09 Genentech, Inc. Pro180 polypeptide
US7256039B2 (en) 1998-05-15 2007-08-14 Genentech, Inc. PRO4405 nucleic acids
AU773187B2 (en) 1998-06-01 2004-05-20 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
AU5134799A (en) 1998-07-30 2000-02-21 Human Genome Sciences, Inc. 98 human secreted proteins
US20030050465A1 (en) 1998-08-10 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000039296A1 (fr) * 1998-12-23 2000-07-06 Immunex Corporation Polypeptides et adn s3939 de lectine
US20030190669A1 (en) 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP4174183B2 (ja) 1999-03-23 2008-10-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードする核酸
EP1074617A3 (fr) 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
PT1200590E (pt) * 1999-08-12 2009-03-24 Agensys Inc Antigénio transmembranar lectina tipo c expresso em cancro da próstata humano e utilizações do mesmo
US7555263B1 (en) * 1999-10-21 2009-06-30 Broadcom Corporation Adaptive radio transceiver
US7300758B2 (en) * 1999-12-09 2007-11-27 Genetech, Inc. Nucleic acid underexpressed in esophageal tumor
JP3467264B2 (ja) * 2000-03-21 2003-11-17 三菱レイヨン株式会社 微生物の培養法
US20030119112A1 (en) 2001-06-20 2003-06-26 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
JP3921367B2 (ja) * 2001-09-26 2007-05-30 日本電気株式会社 データ処理装置および方法、コンピュータプログラム、情報記憶媒体、並列演算装置、データ処理システム
US7202335B2 (en) * 2001-12-06 2007-04-10 Genentech, Inc. PRO300 polypeptides
JP2004187620A (ja) 2002-12-13 2004-07-08 Sumitomo Pharmaceut Co Ltd 腎疾患の疾患マーカーおよびその利用
US20090068098A1 (en) * 2007-08-20 2009-03-12 Kanner Steven B Antibodies and related molecules that bind to 58p1d12 proteins

Also Published As

Publication number Publication date
ES2355428T3 (es) 2011-03-25
US20040038271A1 (en) 2004-02-26
EP1200590B1 (fr) 2009-01-07
CY1111147T1 (el) 2015-06-11
DK1200590T3 (da) 2009-03-16
JP2006204306A (ja) 2006-08-10
PT1200590E (pt) 2009-03-24
AU2004203513A1 (en) 2004-08-26
ATE486938T1 (de) 2010-11-15
US8022174B2 (en) 2011-09-20
AU2006203476A1 (en) 2006-08-31
AU2009200576A1 (en) 2009-03-05
DE60041333D1 (de) 2009-02-26
US6602501B1 (en) 2003-08-05
EP1200590A1 (fr) 2002-05-02
CY1110256T1 (el) 2015-01-14
EP1992695A2 (fr) 2008-11-19
DK1992695T3 (da) 2011-02-14
US7087718B2 (en) 2006-08-08
US7148337B2 (en) 2006-12-12
IL197988A (en) 2011-12-29
EP1992695B1 (fr) 2010-11-03
AU2004203513B2 (en) 2006-05-11
US7598045B2 (en) 2009-10-06
PT1992695E (pt) 2011-01-12
IL147902A (en) 2011-04-28
AU6635100A (en) 2001-03-13
ATE420175T1 (de) 2009-01-15
US20050019872A1 (en) 2005-01-27
AU774436B2 (en) 2004-06-24
DE60045201D1 (de) 2010-12-16
JP2003507042A (ja) 2003-02-25
US20040265898A1 (en) 2004-12-30
AU2009200576B2 (en) 2011-12-22
AU2009200299B2 (en) 2011-12-22
JP2009235109A (ja) 2009-10-15
AU2009200299A1 (en) 2009-02-19
CA2380550C (fr) 2011-02-01
EP1992695A3 (fr) 2009-01-07
WO2001012811A1 (fr) 2001-02-22
ES2317846T3 (es) 2009-05-01
US7153940B2 (en) 2006-12-26
US20070092918A1 (en) 2007-04-26
US20100028374A1 (en) 2010-02-04
JP4373637B2 (ja) 2009-11-25
CA2380550A1 (fr) 2001-02-22

Similar Documents

Publication Publication Date Title
IL147902A0 (en) C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
WO2002046477A3 (fr) Retrovirus endogenes regules positivement dans le cancer de la prostate
TR200201442T2 (tr) Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
WO2002076548A3 (fr) Procedes et appareil pour le traitement d'un tissu malade
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
WO2003070889A3 (fr) Genes specifiques de la prostate et leur utilisation dans la conception ou la therapie
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
EP2365081A3 (fr) Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
AU4174201A (en) 103p2d6: tissue specific protein highly expressed in various cancers
EP0967276A3 (fr) Agent antitumorale comprenant le salmosine
WO2001055391A3 (fr) 84p2a9: proteine specifique de la prostate et du testicule fortement exprimee dans le cancer de la prostate
WO2000035469A3 (fr) Therapie a base de gonadotrophine chorionique destinee au traitement du cancer du sein
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002228940A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001059110A3 (fr) 34p3d7: proteine specifique aux tissus hautement exprimes dans le cancer de la prostate
WO2001059115A3 (fr) Le 83p5g4: proteine specifique de tissus fortement exprime dans le cancer de la prostate
WO2003020954A3 (fr) Acide nucleique et proteine correspondante appelee 205p1b5 utilises dans le traitement et la detection du cancer
WO2001098339A3 (fr) Compositions et procedes de traitement et de diagnostic du cancer du sein
WO2000061610A3 (fr) Nouveau gene specifique de la prostate exprime dans le cancer de la prostate
WO2003020294A8 (fr) Marquage d'aromatase
AU2002243918A1 (en) Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor